Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5672299 | 1.00 | CETP (0.43) | CETPAOC3 | |
| SCHEMBL5670346 | 0.95 | CETP (0.41) | CETPAOC3 | |
| SCHEMBL6568915 | 0.95 | CETP (0.41) | CETPAOC3 | |
| SCHEMBL5670075 | 0.94 | CETP (0.42) | CETPAOC3 | |
| SCHEMBL6570046 | 0.94 | CETP (0.42) | CETPAOC3 | |
| SCHEMBL5668806 | 0.92 | CETP (0.41) | CETP | |
| SCHEMBL6823366 | 0.91 | CETP (0.43) | CETPAOC3 | |
| SCHEMBL1900758 | 0.91 | CETP (0.39) | CETP | |
| SCHEMBL13837709 | 0.91 | CETP (0.39) | CETP | |
| SCHEMBL5669370 | 0.91 | CETP (0.43) | CETPAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469831-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | Pfizer Products Inc. (US) | 2004-10-27 | — | — | EP | disclosed |
| EP-1401399-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMER AND DRUG ASSEMBLIES | Pfizer Products Inc. (US) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003063832-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | PFIZER PRODUCTS INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003000226-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMER AND DRUG ASSEMBLIES | PFIZER PRODUCTS INC. (US) | 2003-01-03 | — | — | WO | disclosed |